ABVX Abivax Corp: Multiplikator Forward P/S

Abivax Corp - logo grafis emiten ABVX

Investing in ABIVAX (ABVX) carries the critical risk of final drug trial failures and a rapid cash burn. The forward P/S trajectory visualizes market expectations, where the current level equals . While demand for intestinal inflammation therapies remains colossal, business success is dictated by regulatory verdicts rather than general economic trends or GDP dynamics.

Abivax - Rasio rega marang prakiraan pendapatan ABVX (periode 04.07.2022 - 13.11.2026)

Abivax Corp (ABVX) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Analisis fundamental perusahaan:Abivax (ABVX)
Produk sing diprodhuksi Abivax Corp

The selection of defensive assets is based on identifying companies with fundamental growth potential, which at ABIVAX (ABVX) is driven by a concentration of leading immunologists and large-scale funding for breakthrough developments. By analyzing the forward price-to-sales multiple chart, an investor assesses the ratio of market demand to expected annual sales, where high line volatility signals the potential for excess profits alongside a significant risk of deep price corrections.

Analisis pesaing ABIVAX

Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ADMA Bio - Multiplikator Forward P/S|PTGX - Multiplikator Forward P/S|IMVT: Multiplikator Forward P/S|KNSA (kiniksa.com) - Rasio rega marang prakiraan pendapatan|GRFS (Grifols) - Multiplikator Forward P/S|Adaptive Biotech (ADPT) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan CLDX (Celldex)|Rasio rega marang prakiraan pendapatan AUPH (Aurinia Corp)|Multiplikator Forward P/S BCRX (BioCryst)|Multiplikator Forward P/S veratx.com VERA|DNTH: Multiplikator forward rega marang pendapatan|PHVS (Pharvaris NV) - Kapitalisasi marang prakiraan pendapatan|ABCL: Multiplikator Forward P/S|Tourmaline (TRML) - Multiplikator Forward P/S|PGEN (Precigen, Inc.) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan PHAR|Multiplikator forward rega marang pendapatan NKTR (Nektar Therapeutics Inc.)|Rasio rega marang prakiraan pendapatan UPB (Upstream Bio, Inc.)|Zenas Biopharma, Inc. - Multiplikator forward rega marang pendapatan|IMNM: Kapitalisasi marang prakiraan pendapatan|GOSS - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan KALV|SEPN: Multiplikator Forward P/S|Pieris Pharma - Rega forward marang dodolan|SVRA (Savara Corp) - Multiplikator Forward P/S|Multiplikator Forward P/S Rigel Corp|Rasio rega marang prakiraan pendapatan AnaptysBio, Inc. (ANAB)|ATXS (astriatx.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan enGene ENGN|RAPT - Multiplikator forward rega marang pendapatan|Aerovate - Multiplikator Forward P/S|ACRS - Multiplikator Forward P/S|KYTX (Kyverna Therapeutics) - Multiplikator forward rega marang pendapatan|tizianalifesciences.com - Rega forward marang dodolan|CABA (Cabaletta Bio) - Multiplikator Forward P/S|Ventyx Biosciences Inc. (VTYX) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Theratechnologies Inc (THTX)|Multiplikator forward rega marang pendapatan Avalo Therapeutics Inc AVTX|Rasio rega marang prakiraan pendapatan Eledon Pharmaceuticals ELDN|AGEN - Multiplikator forward rega marang pendapatan|CLYM: Multiplikator forward rega marang pendapatan|ZURA - Multiplikator Forward P/S|aTyr (ATYR) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan ADAG|IMA (ImageneBio) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Shattuck Therapeutics STTK|Multiplikator Forward P/S EQ|Multiplikator Forward P/S connectbiopharm.com (CNTB)|Multiplikator Forward P/S IMUX (Immunic)|Atara Biotherapeutics, Inc. - Rasio rega marang prakiraan pendapatan|InflaRx GmbH - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake x4pharma.com XFOR|ACET (adicetbio.com) - Multiplikator forward rega marang pendapatan|CELU (Celularity) - Rasio rega marang prakiraan pendapatan|INMB (INmune Bio Corp) - Multiplikator Forward P/S|Multiplikator Forward P/S Barinthus Biotherapeutics Corp|Multiplikator forward rega marang pendapatan KZR (Kezar Life Sciences)|sabbiotherapeutics.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S AKTX (Akari Therapeutics Plc)|Multiplikator Forward P/S Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - Multiplikator Forward P/S|GOVX: Rasio rega marang prakiraan pendapatan|EDSA (Edesa Biotech, Inc.) - Multiplikator forward rega marang pendapatan|IBIO (ibioinc.com) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan CARM|Kapitalisasi marang prakiraan pendapatan XTLB (XTL Biopharmaceuticals Ltd)|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics (BOLT)|HCWB: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S APVO (Aptevo Therapeutics Inc.)|Rega forward marang dodolan AIM|Aditxt Corp - Multiplikator Forward P/S|GRI - Multiplikator Forward P/S|XORTX (XRTX) - Rasio rega marang prakiraan pendapatan|Vyome Therapeutics - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Revelation Biosciences|Multiplikator forward rega marang pendapatan indaptusrx.com (INDP)|Multiplikator Forward P/S SCNI|Multiplikator Forward P/S calcimedica.com (CALI)|Affimed N.V. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ALLK|HOOKIPA - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Ocean Biomedical Inc|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator forward rega marang pendapatan Third Harmonic Bio Inc (THRD)